Company news

Mauna Kea Technologies SA news in 2025

Mauna Kea Technologies SA's news releases, calls and decks from 2025, newest first.

View company

Mauna Kea Technologies and TaeWoong Medical USA Announce Exclusive Partnership to Accelerate Commercial Expansion in the U.S. in Pancreatic Cyst Management

December 3, 2025

Mauna Kea Technologies Receives NMPA Regulatory Approval in China for its Next-Generation Cellvizio® Platform

November 20, 2025

Mauna Kea Technologies Announces the Successful Completion of Its Financial Restructuring and €6M Capital Raise

November 14, 2025

Mauna Kea Technologies Exits Safeguard Proceedings Following Court Approval of its Plan and Initiates Minimum €5M Capital Raise

November 13, 2025

Mauna Kea Technologies Announces It Has Secured Over €5M in Firm Subscription Commitments as Required for Its Capital Increase

October 21, 2025

Mauna Kea Technologies Reports Third Quarter 2025 Revenue Up +16% at Constant Exchange Rates

October 13, 2025

Mauna Kea Technologies Announces the Terms of its Financing Under its Safeguard Plan

October 8, 2025

Mauna Kea Technologies Reaches a Key Milestone in Its Financial Restructuring

October 6, 2025

Mauna Kea Technologies Announces 2025 Half-Year Results

October 1, 2025

Mauna Kea Technologies Presents the Final Terms of its Safeguard Plan

September 22, 2025

Mauna Kea Technologies and Endotherapeutics Announce Cellvizio® First Australian Orders, Advancing CellTolerance® Commercial Expansion

September 18, 2025

Mauna Kea Technologies Unveils the Outlines of its Safeguard Plan to Ensure its Turnaround

September 12, 2025

Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio

September 8, 2025

Mauna Kea Technologies Reports First Half 2025 Revenue

July 28, 2025

Mauna Kea Technologies Enters Australian Market with Endotherapeutics Partnership

July 24, 2025

Mauna Kea Technologies Strengthens its Leading Role in the AI-based Endomicroscopic Imaging Ecosystem with its 14th Patent Granted in the U.S.

July 21, 2025

Mauna Kea Technologies Congratulates Stanford Health Care on Completing 100 Food Intolerance Cases with Cellvizio

July 15, 2025

Mauna Kea Technologies Extends Its Financial Horizon Beyond the Observation Period of the Safeguard Procedure

July 10, 2025

Mauna Kea Technologies Reaches Key Milestone in its Safeguard Procedure

July 10, 2025

Mauna Kea Technologies Announces Results of Its Combined General Meeting of June 5, 2025

June 5, 2025

Mauna Kea Technologies Announces Major AI Breakthrough with Cellvizio in Pancreatic Cystic Lesion Risk Stratification

June 2, 2025

Mauna Kea Technologies Provides Update on Safeguard Proceedings, Strategic Discussions and Operational Progress

May 21, 2025

Mauna Kea Technologies Announces the Availability of Preparatory Documents for the Combined General Meeting of June 5, 2025 and the Instructions for Participation

May 20, 2025

Mauna Kea Technologies Announces Largest Annual Pancreatic Cyst Consortium at Digestive Disease Week® 2025

May 6, 2025

Mauna Kea Technologies: Publication of the 2024 Annual Financial Report

April 30, 2025

Mauna Kea Technologies Announces Another Milestone Year at Digestive Disease Week® 2025 with 8 Presentations Demonstrating the Clinical Value of Cellvizio® in Key Indications

April 28, 2025

Decks in 2025